Context Therapeutics Inc. (CNTX) income statement
CNTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.16−0.01 (-5.10%)
Close on Nov 20, 2026Market cap $14.70MP/E –Yield –
Context Therapeutics Inc. financial ratios
See a number that looks wrong?